Biren Amin
Stock Analyst at Piper Sandler
(4.28)
# 1,340
Out of 4,455 analysts
615
Total ratings
45.3%
Success rate
7.3%
Average return
Main Sectors:
Stocks Rated by Biren Amin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CNTB Connect Biopharma Holdings | Initiated Coverage: Buy | $7 | $2.19 | +219.63% | 1 | Jun 26, 2026 | |
| CBIO Crescent Biopharma | Maintained: Buy | $35 | $18.56 | +88.58% | 24 | Jun 23, 2026 | |
| OCUL Ocular Therapeutix | Maintained: Buy | $31 | $9.84 | +215.04% | 26 | Jun 18, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintained: Buy | $855 | $632.90 | +35.09% | 45 | Jun 2, 2026 | |
| MNPR Monopar Therapeutics | Maintained: Buy | $101 | $87.68 | +15.19% | 8 | Jun 2, 2026 | |
| CNTX Context Therapeutics | Maintained: Buy | $7 | $0.58 | +1,106.90% | 8 | Jun 2, 2026 | |
| CATX Perspective Therapeutics | Maintained: Buy | $16 | $3.04 | +426.32% | 7 | Jun 1, 2026 | |
| IMNM Immunome | Maintained: Buy | $33 | $19.96 | +65.33% | 15 | Jun 1, 2026 | |
| CMPX Compass Therapeutics | Maintained: Buy | $12 → $4 | $2.08 | +92.31% | 7 | Jun 1, 2026 | |
| BBOT BridgeBio Oncology Therapeutics | Maintained: Buy | $21 | $7.40 | +183.78% | 8 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $48 | $16.72 | +187.08% | 8 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $2.13 | +369.48% | 22 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17 → $18 | $9.29 | +93.76% | 16 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 | $22.90 | +52.84% | 10 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $111 | $70.24 | +58.03% | 30 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $62 → $12 | $5.82 | +106.19% | 8 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $5.00 | +120.00% | 4 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $4.00 | +175.00% | 3 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $71 | $38.04 | +86.65% | 12 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $1.55 | +351.61% | 2 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 → $7 | $4.32 | +62.04% | 3 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $16 | $16.85 | -5.04% | 26 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $140 | $108.12 | +29.49% | 1 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $6.34 | +41.96% | 9 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 → $51 | $8.74 | +483.52% | 4 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $63 → $70 | $4.04 | n/a | 4 | May 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $142 → $94 | $168.52 | n/a | 44 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $56 | $28.69 | n/a | 4 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $0.43 | n/a | 20 | Jul 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $19 | $9.53 | n/a | 2 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $8 → $7 | $3.03 | n/a | 11 | Mar 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 → $51 | $4.26 | n/a | 2 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $59 → $34 | $0.9435 | n/a | 2 | Feb 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 | $3.05 | n/a | 5 | Feb 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $32 | $4.10 | n/a | 2 | Jan 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $51 | $3.68 | n/a | 1 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $39 → $109 | $2.10 | n/a | 3 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $43 → $60 | $4.25 | n/a | 18 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.61 | n/a | 3 | Dec 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $15 → $10 | $2.52 | n/a | 2 | Sep 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $10 → $9 | $3.40 | n/a | 12 | Aug 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $36 → $18 | $55.08 | n/a | 32 | Jul 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $41 | $56.52 | n/a | 1 | Jul 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $18 → $2 | $4.37 | n/a | 4 | May 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $0.0004 | n/a | 1 | Mar 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 → $11 | $5.55 | n/a | 3 | Dec 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $12 | $63.15 | n/a | 10 | Nov 8, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 → $3.5 | $8.71 | n/a | 4 | Nov 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $10 → $1 | $0.0015 | n/a | 19 | Oct 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $15 → $7.5 | $35.26 | n/a | 19 | Aug 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $26 | $0.0001 | n/a | 3 | Jun 18, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $17 | $13.49 | n/a | 1 | Jun 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $12 | $148.21 | n/a | 1 | Mar 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $155 | $491.34 | n/a | 1 | Jul 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $5.10 | n/a | 1 | Jun 22, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 | $2.83 | n/a | 7 | Jun 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 | $1.71 | n/a | 9 | May 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 → $15 | $32.03 | n/a | 10 | Mar 10, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 | $42.15 | n/a | 7 | Jan 25, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $6 → $8.75 | $6.88 | n/a | 7 | Jan 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.5 | $3.78 | n/a | 7 | Jan 12, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $0.000001 | n/a | 1 | Mar 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 → $11 | $59.74 | n/a | 7 | Mar 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $1.25 | n/a | 1 | Feb 22, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $6 → $7 | $1.03 | n/a | 6 | Oct 30, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $5 | $0.1831 | n/a | 1 | Aug 22, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $63.65 | n/a | 7 | May 15, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $6 → $4 | $54.77 | n/a | 2 | May 2, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 | $127.88 | n/a | 1 | Jan 27, 2010 |
Connect Biopharma Holdings
Jun 26, 2026
Initiated Coverage: Buy
Price Target: $7
Current: $2.19
Upside: +219.63%
Crescent Biopharma
Jun 23, 2026
Maintained: Buy
Price Target: $35
Current: $18.56
Upside: +88.58%
Ocular Therapeutix
Jun 18, 2026
Maintained: Buy
Price Target: $31
Current: $9.84
Upside: +215.04%
Regeneron Pharmaceuticals
Jun 2, 2026
Maintained: Buy
Price Target: $855
Current: $632.90
Upside: +35.09%
Monopar Therapeutics
Jun 2, 2026
Maintained: Buy
Price Target: $101
Current: $87.68
Upside: +15.19%
Context Therapeutics
Jun 2, 2026
Maintained: Buy
Price Target: $7
Current: $0.58
Upside: +1,106.90%
Perspective Therapeutics
Jun 1, 2026
Maintained: Buy
Price Target: $16
Current: $3.04
Upside: +426.32%
Immunome
Jun 1, 2026
Maintained: Buy
Price Target: $33
Current: $19.96
Upside: +65.33%
Compass Therapeutics
Jun 1, 2026
Maintained: Buy
Price Target: $12 → $4
Current: $2.08
Upside: +92.31%
BridgeBio Oncology Therapeutics
Jun 1, 2026
Maintained: Buy
Price Target: $21
Current: $7.40
Upside: +183.78%
Jun 1, 2026
Maintained: Buy
Price Target: $48
Current: $16.72
Upside: +187.08%
May 29, 2026
Maintained: Buy
Price Target: $10
Current: $2.13
Upside: +369.48%
May 13, 2026
Maintained: Buy
Price Target: $17 → $18
Current: $9.29
Upside: +93.76%
May 13, 2026
Maintained: Buy
Price Target: $35
Current: $22.90
Upside: +52.84%
May 12, 2026
Maintained: Buy
Price Target: $111
Current: $70.24
Upside: +58.03%
May 12, 2026
Downgraded: Hold
Price Target: $62 → $12
Current: $5.82
Upside: +106.19%
May 11, 2026
Maintained: Buy
Price Target: $11
Current: $5.00
Upside: +120.00%
May 8, 2026
Maintained: Buy
Price Target: $11
Current: $4.00
Upside: +175.00%
Apr 30, 2026
Maintained: Buy
Price Target: $71
Current: $38.04
Upside: +86.65%
Apr 13, 2026
Maintained: Buy
Price Target: $7
Current: $1.55
Upside: +351.61%
Mar 30, 2026
Maintained: Hold
Price Target: $5 → $7
Current: $4.32
Upside: +62.04%
Mar 11, 2026
Maintained: Hold
Price Target: $16
Current: $16.85
Upside: -5.04%
Feb 26, 2026
Maintained: Buy
Price Target: $140
Current: $108.12
Upside: +29.49%
Feb 25, 2026
Maintained: Buy
Price Target: $9
Current: $6.34
Upside: +41.96%
Oct 20, 2025
Maintained: Buy
Price Target: $35 → $51
Current: $8.74
Upside: +483.52%
May 19, 2023
Maintained: Buy
Price Target: $63 → $70
Current: $4.04
Upside: n/a
Mar 3, 2022
Downgraded: Hold
Price Target: $142 → $94
Current: $168.52
Upside: n/a
Aug 24, 2021
Reiterated: Buy
Price Target: $56
Current: $28.69
Upside: n/a
Jul 23, 2021
Reiterated: Buy
Price Target: $25
Current: $0.43
Upside: n/a
Mar 17, 2021
Maintained: Buy
Price Target: $14 → $19
Current: $9.53
Upside: n/a
Mar 15, 2021
Rated: Buy
Price Target: $8 → $7
Current: $3.03
Upside: n/a
Mar 12, 2021
Reiterated: Buy
Price Target: $34 → $51
Current: $4.26
Upside: n/a
Feb 16, 2021
Downgraded: Hold
Price Target: $59 → $34
Current: $0.9435
Upside: n/a
Feb 10, 2021
Reiterated: Buy
Price Target: $21
Current: $3.05
Upside: n/a
Jan 15, 2021
Reiterated: Buy
Price Target: $27 → $32
Current: $4.10
Upside: n/a
Jan 11, 2021
Initiated Coverage: Buy
Price Target: $51
Current: $3.68
Upside: n/a
Dec 21, 2020
Maintained: Buy
Price Target: $39 → $109
Current: $2.10
Upside: n/a
Dec 21, 2020
Maintained: Buy
Price Target: $43 → $60
Current: $4.25
Upside: n/a
Dec 9, 2020
Downgraded: Hold
Price Target: n/a
Current: $1.61
Upside: n/a
Sep 14, 2020
Downgraded: Hold
Price Target: $15 → $10
Current: $2.52
Upside: n/a
Aug 7, 2020
Maintained: Hold
Price Target: $10 → $9
Current: $3.40
Upside: n/a
Jul 29, 2020
Maintained: Hold
Price Target: $36 → $18
Current: $55.08
Upside: n/a
Jul 7, 2020
Initiated Coverage: Buy
Price Target: $41
Current: $56.52
Upside: n/a
May 29, 2020
Downgraded: Hold
Price Target: $18 → $2
Current: $4.37
Upside: n/a
Mar 27, 2020
Initiated Coverage: Buy
Price Target: $6
Current: $0.0004
Upside: n/a
Dec 3, 2019
Maintained: Buy
Price Target: $6 → $11
Current: $5.55
Upside: n/a
Nov 8, 2019
Downgraded: Hold
Price Target: $12
Current: $63.15
Upside: n/a
Nov 12, 2018
Reiterated: Hold
Price Target: $4 → $3.5
Current: $8.71
Upside: n/a
Oct 10, 2018
Downgraded: Hold
Price Target: $10 → $1
Current: $0.0015
Upside: n/a
Aug 10, 2018
Reiterated: Hold
Price Target: $15 → $7.5
Current: $35.26
Upside: n/a
Jun 18, 2018
Reiterated: Buy
Price Target: $21 → $26
Current: $0.0001
Upside: n/a
Jun 5, 2018
Initiated Coverage: Buy
Price Target: $17
Current: $13.49
Upside: n/a
Mar 19, 2018
Initiated Coverage: Buy
Price Target: $12
Current: $148.21
Upside: n/a
Jul 11, 2017
Initiated Coverage: Buy
Price Target: $155
Current: $491.34
Upside: n/a
Jun 22, 2017
Reiterated: Buy
Price Target: $17
Current: $5.10
Upside: n/a
Jun 6, 2017
Reiterated: Buy
Price Target: $47
Current: $2.83
Upside: n/a
May 15, 2017
Reiterated: Hold
Price Target: $3
Current: $1.71
Upside: n/a
Mar 10, 2017
Reiterated: Hold
Price Target: $9 → $15
Current: $32.03
Upside: n/a
Jan 25, 2017
Reiterated: Hold
Price Target: $5
Current: $42.15
Upside: n/a
Jan 18, 2017
Downgraded: Hold
Price Target: $6 → $8.75
Current: $6.88
Upside: n/a
Jan 12, 2017
Reiterated: Hold
Price Target: $1.5
Current: $3.78
Upside: n/a
Mar 9, 2016
Reiterated: Buy
Price Target: $9
Current: $0.000001
Upside: n/a
Mar 9, 2016
Maintained: Buy
Price Target: $12 → $11
Current: $59.74
Upside: n/a
Feb 22, 2016
Maintained: Buy
Price Target: $15
Current: $1.25
Upside: n/a
Oct 30, 2015
Rated: Buy
Price Target: $6 → $7
Current: $1.03
Upside: n/a
Aug 22, 2014
Downgraded: Hold
Price Target: $5
Current: $0.1831
Upside: n/a
May 15, 2014
Initiated Coverage: Buy
Price Target: $15
Current: $63.65
Upside: n/a
May 2, 2014
Rated: Hold
Price Target: $6 → $4
Current: $54.77
Upside: n/a
Jan 27, 2010
Maintained: Buy
Price Target: $29
Current: $127.88
Upside: n/a